SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Endocare (ENDO)
ENDO 0.00010000.0%Oct 30 3:39 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: jim heger9/29/2002 12:32:41 PM
  Read Replies (1) of 99
 
I don't seriously

expect to revive this board - buy you never know. This company is in a space that has big growth written all over it - we boomers are going to need what ENDO can deliver.
Some positives: 1) large and growing demand for proven
treatments
2) approved competitively priced product to meet
demand
3) large , experienced sales force
4) management that has skillfully brought the
co. through development to
commercialization
5) platform potential - early success could
be leveraged with new product offerings
6) perhaps, most important - a stock market
that has been beaten to within an inch of
a bottom - providing a washout base on
which to build.
there are ,of course, many questions:
- institutions have shorted heavily - why?
- for all its skill, management is young &
may not know know how to reach the next
level
- bracchy seed competition, may win the most
favored treatment
for all its risks, it seems to me that here in the low teens
the stock is a good buy.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext